Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can special goggles reduce CRPS pain? new study tests prism therapy

NCT ID NCT07370012

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether wearing prism goggles during pointing exercises can reduce pain in people with Complex Regional Pain Syndrome (CRPS) type I. Fifty-four patients with CRPS after a wrist fracture or surgery were split into two groups: one used real prism goggles, the other used sham goggles. Both groups also received standard physical therapy. The goal was to see if prism adaptation therapy could lower pain intensity and improve other symptoms like joint movement.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
prism adaptation therapy using prismatic-lens goggles
What this could lead to
If it works, this could offer a simple, non-drug way to ease pain and improve movement for people with CRPS.
What could go wrong
This is a small, early study with only 54 participants. The results may not apply to everyone, and the therapy might not work better than a sham treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

54 people

The number who actually took part.

Started

Oct 2023

Finished

May 2024

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria * Individuals aged between 18 and 75 years * Patients diagnosed with CRPS Type 1 according to the IASP 2003 CRPS Budapest diagnostic criteria * Presence of traumatic etiologies, including surgical procedures, fractures, or immobilization * Patients who consented to participate and provided written informed consent Exclusion Criteria * History of inflammatory, autoimmune, hematologic, or neoplastic diseases * Diabetes mellitus, thyroid disorders, hepatic or renal failure * History of cranial trauma or cranial surgery within the preceding 6 months * Use of diuretics, anti-inflammatory, antineoplastic, corticosteroid, immunosuppressive, antidepressant, or anxiolytic medications within the past 2 months * Use of anticholinergic medications within the past 7 days * Active ocular infection, inflammation, allergy, or recent use/exposure to ophthalmic drops * History of lens or ocular surgery within the last 3 months * Current or previous use of glasses or contact lenses, or diagnosis of refractive error ≥0.5 diopters * Peripheral nerve injury in the affected hand consistent with CRPS Type 2 as per Budapest criteria * Known progressive or non-progressive peripheral or central nervous system disorders * CRPS Type 1 developing subsequent to central nervous system injury (e.g., stroke) * Patients in the acute phase following primary or secondary tendon repair * Presence of comorbid conditions likely to impair functionality and health-related quality of life, such as decompensated heart failure, chronic kidney failure, or malignancy * Comorbid diseases affecting hand function, including rheumatoid arthritis, psoriatic arthritis, or other inflammatory disorders involving the hand * Joint restriction and/or muscle weakness in the affected extremity that would impede movement * History of acute upper-extremity deep vein thrombosis or arterial thrombosis * Arterial or venous injury and/or history of arterial or venous repair surgery * History of heavy alcohol consumption or inappropriate opioid use * Inadequately treated psychiatric disorders or conditions, such as major depression, anxiety, or schizophrenia * Recurrent diagnosis of CRPS Type 1, defined as patients experiencing repeated episodes

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Complex regional pain syndrome I (CRPS I) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ankara Etlik City Hospital

    Ankara, Ankara, 06170, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.